Fevipiprant, a DP2 receptor antagonist, inhibits eosinophil migration towards mast cells
Fevipiprant, a DP2 receptor antagonist, inhibits eosinophil migration towards mast cells. Shamri R, Dubois G, Erpenbeck VJ, Mankuta D, Sandham DA, Levi-Schaffer F. Clin Exp Allergy. 2019 Feb;49(2):255-257. doi: 10.1111/cea.13304. Epub 2018 Nov 25. PMID: 30379368
Mark your calendars!Our next webinar and general assembly will take place on: 🗓 October 8🕓 4:00 PM CET📍 Online Details on the webinar topic and speakers will follow soon —
We’re excited to announce the upcoming launch of the Junior Member Insights Series, a brand-new initiative created to support collaboration, learning, and networking among our society’s junior members. This
Over the past eight years, EMBRN has become a cornerstone in the field, fostering groundbreaking research that has enhanced our understanding of mast cell and basophil